Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BI-1808 |
Synonyms | |
Therapy Description |
BI-1808 is an antibody that targets TNFR2, potentially leading to modulation of the antitumor immune response (Cancer Res 2022;82(12_Suppl):Abstract nr 4156). |